Compare BDRX & SGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDRX | SGRX |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United Kingdom | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.7M |
| IPO Year | 2015 | 2018 |
| Metric | BDRX | SGRX |
|---|---|---|
| Price | $0.46 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 411.5K |
| Earning Date | 09-11-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $0.56 |
| 52 Week High | $8.96 | $1.92 |
| Indicator | BDRX | SGRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.36 | 27.23 |
| Support Level | N/A | $0.56 |
| Resistance Level | $1.52 | $1.88 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 3.93 | 12.56 |
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.